Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast Cancer Resection

The study findings suggest that PSO should be offered to all patients with BRCA1/2 breast cancer who undergo surgery with curative intent to reduce risk of death. In particular, PSO should be offered to patients with the BRCA1 variant at the time of breast surgery.